Advertisement
CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Stock Overview

Explore CRISPR Therapeutics AG’s financial performance, market position, analyst ratings, and future outlook.

CRSP●NASDAQ
HealthcareBiotechnology
$56.95
$4.87(9.35%)
U.S. Market opens in 16h 6m
Advertisement

CRISPR Therapeutics AG (CRSP)

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-8.76
EPS (TTM)$-6.17
ROE-0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$49.87
3 Months$54.60
1 Year Target$45.45

CRSP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CRISPR Therapeutics AG (CRSP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $45.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.76 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
9.35%
5-Day Change
1.01%
1-Month Change
6.29%
3-Month Change
-5.08%
6-Month Change
-2.11%
Year-to-Date (YTD) Change
8.60%
1-Year Change
49.67%
3-Year Change
-9.66%
5-Year Change
-49.73%
All-Time (Max) Change
304.19%

Contact Information

https://www.crisprtx.com
41 41 561 32 77
Baarerstrasse 14, Zug, NaN, 6300

Company Facts

393 Employees
IPO DateOct 19, 2016
CountryCH
Actively Trading

Frequently Asked Questions